- Home
- IKT vs ADUR Comparison
IKT vs ADUR Comparison
Compare IKT & ADUR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IKT
- ADUR
- Stock Information
- Founded
- IKT 2008
- ADUR 2011
- Country
- IKT United States
- ADUR Canada
- Employees
- IKT N/A
- ADUR N/A
- Industry
- IKT Biotechnology: Pharmaceutical Preparations
- ADUR
- Sector
- IKT Health Care
- ADUR
- Exchange
- IKT Nasdaq
- ADUR NYSE
- Market Cap
- IKT 159.2M
- ADUR 154.9M
- IPO Year
- IKT 2020
- ADUR N/A
- Fundamental
- Price
- IKT $3.05
- ADUR $6.33
- Analyst Decision
- IKT Strong Buy
- ADUR
- Analyst Count
- IKT 2
- ADUR 0
- Target Price
- IKT $6.50
- ADUR N/A
- AVG Volume (30 Days)
- IKT 451.1K
- ADUR 74.3K
- Earning Date
- IKT 11-14-2024
- ADUR 01-01-0001
- Dividend Yield
- IKT N/A
- ADUR N/A
- EPS Growth
- IKT N/A
- ADUR N/A
- EPS
- IKT N/A
- ADUR N/A
- Revenue
- IKT $1.00
- ADUR $247,485.00
- Revenue This Year
- IKT N/A
- ADUR N/A
- Revenue Next Year
- IKT N/A
- ADUR N/A
- P/E Ratio
- IKT N/A
- ADUR N/A
- Revenue Growth
- IKT N/A
- ADUR 98.59
- 52 Week Low
- IKT $1.12
- ADUR $1.34
- 52 Week High
- IKT $4.20
- ADUR $7.00
- Technical
- Relative Strength Index (RSI)
- IKT 51.80
- ADUR N/A
- Support Level
- IKT $2.90
- ADUR N/A
- Resistance Level
- IKT $4.20
- ADUR N/A
- Average True Range (ATR)
- IKT 0.41
- ADUR 0.00
- MACD
- IKT -0.07
- ADUR 0.00
- Stochastic Oscillator
- IKT 11.54
- ADUR 0.00
About IKT Inhibikase Therapeutics Inc.
Inhibikase Therapeutics Inc is a a clinical-stage pharmaceutical company developing protein kinase inhibitor therapeutics to modify the course of Parkinson's disease ("PD"), Parkinson's-related disorders and other diseases of the Abelson Tyrosine Kinases. Its multi-therapeutic pipeline has a primary focus on neurodegeneration and its program utilizing Risvodetinib (also known as IkT-148009), a selective inhibitor of the non-receptor Abelson Tyrosine Kinases, targets the treatment of Parkinson's disease inside and outside the brain as well as other diseases that arise from Abelson Tyrosine Kinases.
About ADUR ADURO CLEAN TECHNOLOGIES INC
Aduro Clean Technologies Inc is a developer of patented water-based technologies to chemically recycle plastics and transform heavy crude and renewable oils into feedstocks and higher-value fuels. The company's technology activates unique properties of water in a chemistry platform that operates at relatively low temperatures and costs.